Tag: Collaboration

BI & MD Anderson Form Research and Development Center

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center(link is external) announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for v...

Onconova and Mission Bio Announced Collaboration to Utilize TapestriⓇ Platform

Onconova Therapeutics, Inc., a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), and Mission Bio, the ...

Italfarmaco, Neupharma Agreed to Develop and Commercialize Inhaled Teicoplanin

agreement
Italfarmaco SpA, a member company, has entered into a binding term sheet agreement with Neupharma for an exclusive option to develop and commercialize inhaled teicoplanin. Intravenously administered t...

US Pharmacopeia and British Pharmacopoeia Signed Memorandum of Understanding

cooperation handshake
The US Pharmacopeia (USP) and its UK counterpart the British Pharmacopoeia (BP) signed a memorandum of understanding formalizing a partnership to strengthen quality standards for medicines. While t...

Biodesix and Immodulon Therapeutics Announced Biomarker Research Collaboration

tubes
Biodesix Inc. and Immodulon Therapeutics Limited, the immune-oncology company, announced that they have entered into a biomarker research collaboration. The partnership will focus on the analysis of t...

Servier Australia and BioCurate Agreed to Share Expertise to Accelerate the Discovery of New Drugs

Servier Australia, the subsidiary of Servier Group, an international pharmaceutical company, and BioCurate, a joint venture company of Monash University and The University of Melbourne with support fr...

BI and Bridge Biotherapeutics in New Collaboration and License Agreement

Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxi...

Bayer, BMS and Ono in Clinical Collaboration Agreement

pills
Bayer, Bristol-Myers Squibb Company and Ono Pharmaceutical Co.,Ltd. (“Ono”) announced today that the three companies have entered into a clinical collaboration agreement to evaluate the combination of...

Gilead and Galapagos Signed Research and Development Collaboration

Gilead Sciences, Inc. and Galapagos NV announced that they have entered into a 10-year global research and development collaboration. Through this agreement, Gilead will gain access to an innovative p...

IBTC Announced Partnership with Karyopharm to Accelerate Treatment of Brain Cancer

cancer drugs
The Ivy Brain Tumor Center at the Barrow Neurological Institute has announced a partnership with Karyopharm Therapeutics to accelerate the treatment of brain cancer. The Ivy Brain Tumor Center will em...

Immuno-Oncology Imaging Company in Collaboration with Roche

roche
ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreeme...

NCDA Partners with Teva

NCDA to announce the launch of a new partnership with Teva to foster dialogue around the specific challenges raised by multiple chronic conditions (MCC) in the context of Universal Health Coverage (UH...

Drug Discovery Collaboration Announced by Confo Therapeutics and DyNAbind

drug-discovery
Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR). The collaboration will c...

Lannett to be Exclusive US Distributor of Dantrolene

Lannett Company, Inc. today announced that it has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Capsules 25 mg, 50 mg and 100 mg. ...

Liquidia Amended Collaboration Agreement with GlaxoSmithKline

gsk
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT® technology, announced t...

Cooperation on Development of Immuno-Oncology Therapies Announced by Gilead and Carna Biosciences

gilead sciences
Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno...